Diniz-Lima I, Fonseca L, Dos Reis J, Decote-Ricardo D, Morrot A, Previato J
Braz J Microbiol. 2023; 54(2):907-919.
PMID: 36840821
PMC: 10235250.
DOI: 10.1007/s42770-023-00936-0.
Chung K, Brown J
Curr Clin Microbiol Rep. 2020; 7(1):1-11.
PMID: 33042730
PMC: 7543870.
DOI: 10.1007/s40588-020-00137-5.
Subramani A, Griggs P, Frantzen N, Mendez J, Tucker J, Murriel J
PLoS One. 2020; 15(8):e0233818.
PMID: 32857777
PMC: 7454990.
DOI: 10.1371/journal.pone.0233818.
Boniche C, Rossi S, Kischkel B, Barbalho F, Moura A, Nosanchuk J
J Fungi (Basel). 2020; 6(1).
PMID: 32121415
PMC: 7151209.
DOI: 10.3390/jof6010031.
Nualnoi T, Kirosingh A, Pandit S, Thorkildson P, Brett P, Burtnick M
PLoS Negl Trop Dis. 2016; 10(12):e0005217.
PMID: 27941991
PMC: 5179125.
DOI: 10.1371/journal.pntd.0005217.
Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?.
Prattes J, Heldt S, Eigl S, Hoenigl M
Curr Fungal Infect Rep. 2016; 10:43-50.
PMID: 27358661
PMC: 4896970.
DOI: 10.1007/s12281-016-0254-5.
Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid.
Kabanda T, Siedner M, Klausner J, Muzoora C, Boulware D
Clin Infect Dis. 2013; 58(1):113-6.
PMID: 24065327
PMC: 3864499.
DOI: 10.1093/cid/cit641.
Fungal-induced cell cycle impairment, chromosome instability and apoptosis via differential activation of NF-κB.
Ben-Abdallah M, Sturny-Leclere A, Ave P, Louise A, Moyrand F, Weih F
PLoS Pathog. 2012; 8(3):e1002555.
PMID: 22396644
PMC: 3291658.
DOI: 10.1371/journal.ppat.1002555.
Capsular Material of Cryptococcus neoformans: Virulence and Much More.
Vecchiarelli A, Monari C
Mycopathologia. 2012; .
PMID: 22314939
DOI: 10.1007/s11046-011-9513-8.
Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells.
Foote J, Mahmoud T, Vale A, Kearney J
J Immunol. 2011; 188(1):57-67.
PMID: 22116821
PMC: 3244511.
DOI: 10.4049/jimmunol.1100783.
Galactoxylomannan-mediated immunological paralysis results from specific B cell depletion in the context of widespread immune system damage.
De Jesus M, Nicola A, Frases S, Lee I, Mieses S, Casadevall A
J Immunol. 2009; 183(6):3885-94.
PMID: 19684080
PMC: 2737596.
DOI: 10.4049/jimmunol.0900449.
Isolation and purification of antigenic components of Cryptococcus.
Wozniak K, Levitz S
Methods Mol Biol. 2008; 470:71-83.
PMID: 19089377
PMC: 3297022.
DOI: 10.1007/978-1-59745-204-5_7.
Macrophage uptake, intracellular localization, and degradation of poly-gamma-D-glutamic acid, the capsular antigen of Bacillus anthracis.
Sutherland M, Kozel T
Infect Immun. 2008; 77(1):532-8.
PMID: 19001075
PMC: 2612234.
DOI: 10.1128/IAI.01009-08.
Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan.
Datta K, Lees A, Pirofski L
Clin Vaccine Immunol. 2008; 15(8):1176-87.
PMID: 18524882
PMC: 2519304.
DOI: 10.1128/CVI.00130-08.
Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1.
De Jesus M, Park C, Su Y, Goldman D, Steinman R, Casadevall A
Med Mycol. 2008; 46(2):153-62.
PMID: 18324494
PMC: 2828395.
DOI: 10.1080/13693780701747182.
In vivo fate and distribution of poly-gamma-D-glutamic acid, the capsular antigen from Bacillus anthracis.
Sutherland M, Thorkildson P, Parks S, Kozel T
Infect Immun. 2008; 76(3):899-906.
PMID: 18195035
PMC: 2258845.
DOI: 10.1128/IAI.01176-07.
Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.
Yauch L, Lam J, Levitz S
PLoS Pathog. 2006; 2(11):e120.
PMID: 17096589
PMC: 1635532.
DOI: 10.1371/journal.ppat.0020120.
Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophages.
Chang Z, Netski D, Thorkildson P, Kozel T
Infect Immun. 2005; 74(1):144-51.
PMID: 16368967
PMC: 1346664.
DOI: 10.1128/IAI.74.1.144-151.2006.
Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo.
Yauch L, Mansour M, Levitz S
Infect Immun. 2005; 73(12):8429-32.
PMID: 16299344
PMC: 1307074.
DOI: 10.1128/IAI.73.12.8429-8432.2005.
Glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, inhibits the progression of group B streptococcal arthritis.
Tissi L, Puliti M, Bistoni F, Mosci P, Kozel T, Vecchiarelli A
Infect Immun. 2004; 72(11):6367-72.
PMID: 15501766
PMC: 523051.
DOI: 10.1128/IAI.72.11.6367-6372.2004.